MRVI, US56600D1072

Maravai LifeSciences stock gains 3.74 percent as market value reaches USD 326.82 million

Published on 09/22/2026 at 09:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Maravai LifeSciences stock reached USD 2.35 on September 21, 2026, up 3.74 percent in the latest quote. Its market value was USD 326.82 million.

MRVI, US56600D1072, Illustration mit AI erstellt.
MRVI, US56600D1072, Illustration mit AI erstellt.

Maravai LifeSciences Holdings, Inc. (ISIN US56600D1072) was quoted at USD 2.35 on Nasdaq on September 21, 2026, up 3.74 percent in the latest available market snapshot. The move came against a weak longer-term record, with the stock down 73.55 percent over the preceding year.

Small-cap valuation remains compressed

The same September 21, 2026 market snapshot placed Maravai LifeSciences at a market capitalization of USD 326.82 million. That valuation was down 12.80 percent over the previous week, making the one-day gain a limited rebound within a much weaker seven-day trend.

The price data also show a sharp distance between the latest USD 2.35 quote and the trailing one-year performance. For investors, the combination of a USD 326.82 million market value and a 73.55 percent annual decline points to a risk profile dominated by execution and financing sensitivity rather than broad market direction.

Recent operating figures need a fresh checkpoint

Maravai LifeSciences stock is linked to a company whose latest operating picture should be judged against a clearly identified reporting period. The available market snapshot supplies the current valuation and performance measures dated September 21, 2026, while the reported percentage changes provide the principal quantified comparison for the stock.

The key comparison is between the 3.74 percent latest-session gain and the 73.55 percent decline over the preceding year. That 77.29 percentage-point gap shows why the daily rise does not by itself establish a lasting change in the company trend.

Nasdaq price sets the reference

Maravai LifeSciences stock was quoted at USD 2.35 on Nasdaq on September 21, 2026. The latest snapshot also recorded a 326.82 million dollar market capitalization as of the same market-data update, giving the closing valuation context for the reference price.

Maravai LifeSciences stock facts

  • Company: Maravai LifeSciences Holdings, Inc.
  • ISIN: US56600D1072
  • Ticker: MRVI
  • Trading venue: Nasdaq
  • Price as of September 21, 2026: USD 2.35
  • Market capitalization: USD 326.82 million as of September 21, 2026
  • Sector / Industry: Health Care / Life Sciences Tools and Services

More news and analyses on Maravai LifeSciences stock

Disclaimer...

en | US56600D1072 | MRVI | boerse | 70152512 | bgmi